The efficacy of mirabegron additional therapy for lower urinary tract symptoms after treatment with α1-adrenergic receptor blocker monotherapy: prospective analysis of elderly men

被引：0
|
作者：
Tomohiro Matsuo
Yasuyoshi Miyata
Katsura Kakoki
Miki Yuzuriha
Akihiro Asai
Kojiro Ohba
Hideki Sakai
机构：
[1] Nagasaki University Graduate School of Biochemical Sciences,Department of Urology
来源：
BMC Urology | / 16卷
关键词：
Mirabegron; Elderly male; Overactive bladder; α1-adrenergic blockers;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Re: Efficacy and Safety of Silodosin in the Treatment of Lower Urinary Tract Symptoms in Elderly Men Taking Antihypertensive Medications Editorial Comment
    Griebling, Tomas L.
    JOURNAL OF UROLOGY, 2018, 200 (04): : 675 - 676
  • [32] ALPHA-1 BLOCKER TREATMENT FOR LOWER URINARY TRACT SYMPTOMS IMPROVE THE INDEX OF DEPRESSION AND ANXIETY: A PROSPECTIVE MULTICENTER STUDY
    Cho, In-Rae
    Cho, Sung-Yong
    Cho, Jin-Seon
    Park, Dong-Su
    Sung, Do-Hwan
    Kim, Young-Sik
    INTERNATIONAL JOURNAL OF UROLOGY, 2014, 21 : A161 - A161
  • [33] Efficacy of the combination of an α1-blocker with an anticholinergic agent in the treatment of lower urinary tract symptoms associated with bladder outlet obstruction
    Athanasopoulos, A
    Perimenis, P
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (14) : 2429 - 2433
  • [34] Role of Bladder Dysfunction in Men with Lower Urinary Tract Symptoms Refractory to Alpha-blocker Therapy: A Video-urodynamic Analysis
    Jiang, Yuan-Hong
    Liao, Chun-Hou
    Kuo, Hann-Chorng
    LUTS-LOWER URINARY TRACT SYMPTOMS, 2018, 10 (01) : 32 - 37
  • [35] What percent of men with lower urinary tract symptoms by prostatic enlargement can continue α1-blocker treatment for a long time?
    Masumori, N.
    Fukuta, F.
    Tsukamoto, T.
    Sato, E.
    Tanaka, Y.
    Horita, H.
    Takeyama, K.
    Sunaoshi, K.
    Miyao, N.
    NEUROUROLOGY AND URODYNAMICS, 2008, 27 (07) : 580 - 580
  • [36] α1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms
    Chiu, George
    Connolly, Peter J.
    Middleton, Steven A.
    Li, Shengjian
    Pulito, Virginia
    Liu, Jingchun
    Baxter, Ellen W.
    Reitz, Allen B.
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2008, 18 (12) : 1351 - 1360
  • [37] BLADDER DYSFUNCTION IN MEN WITH LOWER URINARY TRACT SYMPTOMS REFRACTORY TO ALPHA-BLOCKER THERAPY - A VIDEOURODYNAMIC ANALYSIS AND THE RELATIONSHIP WITH AGE AND PROSTATIC VOLUME
    Wu, S.
    Kuo, H.
    NEUROUROLOGY AND URODYNAMICS, 2015, 34 : S73 - S74
  • [38] Systematic review and meta-analysis on the efficacy and tolerability of mirabegron for the treatment of storage lower urinary tract symptoms/overactive bladder: Comparison with placebo and tolterodine
    Sebastianelli, Arcangelo
    Russo, Giorgio I.
    Kaplan, Steven A.
    McVary, Kevin T.
    Moncada, Ignacio
    Gravas, Stavros
    Chapple, Christopher
    Morgia, Giuseppe
    Serni, Sergio
    Gacci, Mauro
    INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 (03) : 196 - 205
  • [39] Efficacy and safety of simultaneous administration of mirodenafil once daily and an alpha blocker in men with unsatisfactory improvement of lower urinary tract symptoms despite the alpha blocker mono therapy: A multicenter, open-label, prospective study
    Oh, C. Y.
    Cho, J. S.
    Yoo, C.
    Yang, D. Y.
    Chung, B. H.
    Lee, S. H.
    Lee, D. H.
    Cheong, M. S.
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E643 - U379
  • [40] Efficacy of 1-Year Cavacurmin® Therapy in Reducing Prostate Growth in Men Suffering from Lower Urinary Tract Symptoms
    Milanese, Giulio
    Agostini, Edoardo
    De Angelis, Maria Vittoria
    Pretore, Eugenio
    Galosi, Andrea Benedetto
    Castellani, Daniele
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (04)
12345